Shares of health-care companies rose amid optimism about the legislative outlook.
Drug maker Bristol-Myers Squibb could see a $1 billion sales boost from wider use of its cancer drug Opdivo after release of promising clinical-trial data, according to brokerage Leerink.
Continue Reading Below
Federal prosecutors in Brooklyn asked a judge to prevent controversial pharma executive Martin Shkreli from making public commentary about his ongoing securities-fraud trial.
(-By Rob Curran, email@example.com)
(END) Dow Jones Newswires
July 05, 2017 16:24 ET (20:24 GMT)